Growing Up Too Fast: A Primary Care Approach to Precocious Puberty

About this course

Precocious puberty (PP) is defined as the onset of secondary sexual characteristics before age 8 in girls and before age 9 in boys. While some cases reflect benign pubertal variants, others may indicate an underlying pathology, including central nervous system abnormalities or hormonal imbalances. Given the increasing trend of early pubertal onset, it is important for primary care physicians (PCPs) to distinguish between benign pubertal variants and pathological precocious puberty to ensure appropriate referral and management.

The two major categories of precocious puberty are central precocious puberty (CPP) and peripheral precocious puberty (PPP). CPP accounts for the vast majority of PP cases, particularly in girls. Understanding CPP and distinguishing progressive from nonprogressive forms is essential, as it directly impacts management decisions. Progressive CPP can lead to early epiphyseal closure, reduced adult height, and psychosocial challenges, typically requiring timely treatment. In contrast, nonprogressive forms often only need surveillance and monitoring. Recognizing this difference allows PCPs to monitor nonprogressive cases appropriately while ensuring children with progressive CPP receive prompt specialist referral and intervention.

Gonadotropin-releasing hormone agonists (GnRHa) are the standard of care for managing progressive central precocious puberty (CPP). GnRHa therapy works by suppressing pituitary gonadotropin release and halting further sexual maturation. Although GnrHa therapy is initiated by specialists, PCPs should understand their indications, efficacy, safety, and long-term outcomes to effectively counsel families and support patient care.

This e-learning module aims to equip primary care physicians with a comprehensive understanding of precocious puberty, with further exploration of the diagnosis and management of its most common type – central precocious puberty.